Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
George Buchanan, MD
Healthcare Provider Professor Emeritus
The University of Texas Southwestern
Medical Center
5323 Harry Hines Blvd
Dallas, Texas, United States
Dr. George R. Buchanan is a Professor of Pediatrics at the University of Texas Southwestern Medical Center (UT Southwestern) in Dallas, Texas. He received his medical degree from the University of Chicago in 1970, followed by pediatric residency at Children’s Memorial Hospital in Chicago and hematology-oncology fellowship at Children’s Hospital Boston, Dana Farber Cancer Institute, and Harvard Medical School.
Dr. Buchanan has been at UT Southwestern since 1977 and is actively involved in the diagnosis and management of children and adolescents with blood diseases. He had been a national leader in investigator-initiated and multicenter collaborative research in many areas of hematology, including sickle cell disease, other anemias, bleeding disorders, and childhood cancer. He has had keen interest in training and mentoring young physician researchers and developing new treatment approaches for children affected with blood disorders and cancer.
Representative Publications:
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members
Prevalence of intracardiac shunting in children with sickle cell disease and stroke
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease
+myBinderRelated Content
-
Boston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
Wanda Whitten-Shurney, MDDr. Wanda Whitten-Shurney is a pediatric...
-
Women with Sickle Cell Disease and Prenatal Care: What to Know During PregnancyPrenatal care is health care you get whi...
-
Osheiza Abdulmalik, PhDDr. Abdulmalik’s research interests br...
-
Health Care Utilization Trajectories and Associated Factors for Transitioning Adolescents/Young Adults with Sickle C...Limited research had explored health car...
-
FDA Approves Novel Treatment to Target Abnormality in Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Doris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
